Catalyst Wire Dossier Catalyst Wire Dossier

Cervarix

human papillomavirus vaccine, bivalent · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

57 regulatory and trial events tracked for Cervarix, covering 2007-12-12 to 2026-07-09. Get the full timeline:

Most recent: EMA Authorised: Cervarix (human papillomavirus1 type 16 L1 protein;human papillomavirus type 18 L1 protein) — GlaxoSmithKline Biologicals S.A.

See pricing